Trials / Completed
CompletedNCT01742312
Effects of Chemotherapy on Muscle Mass and Exercise Performance in Patients With Oesophageal Cancer.
Effect of Neoadjuvant Chemotherapy on Muscle Mass and Peri-operative Cardiorespiratory Performance in Patients Undergoing Oesophageal Cancer- a Pilot Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- University of Nottingham · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Curative treatment for oesophageal cancer involves undertaking chemotherapy followed by an operation to remove the tumour. Chemotherapy has several effects upon the body, including effects upon the systems that control the creation and breakdown of muscle. We aim to review these effects by recording changes in the amount of exercise patients are able to undertake after chemotherapy and reviewing changes in muscle mass.
Detailed description
We aim to review the effects of chemotherapy on skeletal muscle mass and cardio-respiratory performance in patients with oesophageal adenocarcinoma. All patients will be assessed by a Consultant Anaesthetist and a medical member of the Research team before commencing chemotherapy and after finishing their course. These assessments include a nutritional assessment, performance status assessments, blood assays, dual energy X-ray absorptiometry (DEXA) scans, cardio-pulmonary exercise (CPEX) testing and a muscle biopsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | DEXA scan | all patients will undertake a full body DEXA scan before and after chemotherapy |
| PROCEDURE | Muscle biopsy | All patients will have a muscle biopsy before and after chemotherapy |
| OTHER | cardio-pulmonary exercise testing (CPEX) | patients will undertake exercise in the form of an exercise bike whilst having their cardiac and ventilatory performance analysed. This will take place before and after neoadjuvant chemotherapy |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2012-12-05
- Last updated
- 2016-02-18
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01742312. Inclusion in this directory is not an endorsement.